Research and Innovation
Drugging the Undruggable: Scientists Achieve Million-fold Leap in Targeting Elusive Cancer Proteins
A new study led by Dr. Marianne D. Sadar, distinguished scientist at BC Cancer and professor of pathology and laboratory medicine at the UBC …
B.C. Launches World-First Technology to Revolutionize Hereditary Cancer Prevention
Dr. Kasmintan Schrader, co-director of BC Cancer’s Hereditary Cancer Program, is part of the team that developed POAga.
Is There a Link Between Sugar and Cancer?
All cells in the body, including cancer cells, use sugar or glucose for energy. But sugar does not directly cause cancer or make cancer …
Expanding Clinical Cancer Trials Across B.C.
In the past, participating in a clinical trial often meant travelling — or temporarily relocating — to a major urban cancer centre. Thanks to donor support, BC Cancer is expanding …
BC Cancer’s Chief Medical Officer Dr. Paris-Ann Ingledew
BC Cancer’s new chief medical officer on how donor support is expanding research, treatment and access to care across the province.
A Breakthrough in Hereditary Cancer Testing
Dr. Kasmintan Schrader, co-medical director of BC Cancer’s Hereditary Cancer Program, says POAga will transform hereditary cancer care for generations …
Dr. Carlos Uribe: Combining Empathy With PET/CT Innovation
Dr. Carlos Uribe is the molecular imaging and therapy physics lead at BC Cancer and part of the team that helped bring a …
Ignite Progress: BC Cancer’s Dr. Srinivas Raman Gives Back
Dr. Srinivas Raman grew up in Vancouver and completed degrees in mechanical engineering and medicine at UBC, so after working for five years in …
5 B.C.-Led Advances in Women’s Cancers
Women’s cancers have long been underfunded and understudied worldwide. On International Women’s Day, we celebrate the success of donor-supported BC Cancer breakthroughs driving change …
BC Cancer Researchers Receive CIHR Cancer Prevention Team Grants
The Government of Canada has announced more than $41 million in funding through the Canadian Institutes of Health Research (CIHR) to advance innovative cancer …